ARTICLE | Clinical News
Galaczym regulatory update
October 10, 2011 7:00 AM UTC
The European Commission granted Orphan Drug designation for Galaczym from Zymenex's Ace Biosciences A/S subsidiary to treat globoid cell leukodystrophy (Krabbe disease), a hereditary disease caused by...